CKPT Checkpoint Therapeutics, Inc. Sof marja

Checkpoint Therapeutics, Inc - CKPT emitenti grafik logotipi

Checkpoint Therapeutics yangi dori vositalari uchun chegirmali narxlarni taklif qilish orqali bozorni agressiv ravishda egallashni rejalashtirmoqda. Tijoriy daromadlilik darajasi ushbu strategiyaning samaradorligini kuzatishga yordam beradi, bunda -137822.00 ushbu ko'rsatkichning joriy qiymatini ko'rsatadi. Biznes sintez va sinovlarni autsorsing qilishga tayanadi, bu esa yetkazib beruvchilarga bog'liqlikni yuzaga keltirsa-da, FDA tasdig'idan so'ng yuqori foyda masshtablanishini ta'minlaydi.

Checkpoint Therapeutics (CKPT) Sof foyda marjasi: 04.07.2022 - 07.06.2025 davri uchun

Checkpoint Therapeutics Inc (CKPT) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahlili:Checkpoint Therapeutics, CKPT
Checkpoint Therapeutics, Inc yetakchi tovari

Checkpoint Therapeutics melanoma bilan kurashish uchun maxsus immunoterapiyalarni ishlab chiqishga e'tibor qaratadi. Bunday ishlanmalarning tijoratlashtirish samaradorligi bevosita kompaniyaning foyda marjalarini aks ettiradi. Ushbu ko'rsatkich umumiy daromadning sof foyda ulushini belgilab, operatsion xarajatlarning haqiqiy tuzilishini ochib beradi. Ushbu qiymatning oshishi xarajatlarni optimallashtirishdan dalolat beradi. Biroq, kompaniyaning foyda marjalarini tahlil qilish mahsulot sotuvlarining umumiy hajmini hisobga olishni talab qiladi.

Checkpoint Therapeutics raqobatchilari tahlili

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sof foyda bo'yicha sotuv rentabelligi OS Therapies Inc. OSTX|Sof marja Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Sof marja|ANL - Sof marja|Sof marja verupharma.com|TPST: Sotuvning sof marjinal rentabelligi|XLO - Kompaniya sotuv marjasi|Sof marja Renovaro|Sotuvning sof marjinal rentabelligi muraloncology.com|Sotuvning sof marjinal rentabelligi KAPA|Kompaniya sotuv marjasi OnKure Therapeutics, Inc.|Sotuvning sof marjinal rentabelligi GDTC (w2.cytomed.sg)|CRIS - Sof foyda bo'yicha sotuv rentabelligi|Apollomics - Sotuvning sof marjinal rentabelligi|Tharimmune Corp (THAR) - Sof foyda bo'yicha sotuv rentabelligi|ADVB: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi SBFM (Sunshine Biopharma)|Sof marja Xenetic Bio (XBIO)|Sof marja SLRX (Salarius Pharma)|Kitov Pharma - Sof foyda bo'yicha sotuv rentabelligi|American Oncology Network (AONC) - Sof marja|BeiGene - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)